Bastiaan Leewis is a seasoned biotechnology professional having served different roles in the ATMP field over the last 18 years. He is currently the senior vice president of MSAT at MeiraGTx, a leading gene therapy company with development and manufacturing locations in New York, Ireland, and London. Based in London, he specializes in the scalable production and manufacturing of viral vectors for advanced therapies, particularly adeno-associated virus (AAV) systems.